Study of a new drug for healthy adults and kidney patients on dialysis
Part of Infections, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a new drug called AZD7760 in two groups: healthy adults (Phase I) and adults with end-stage kidney disease who are on hemodialysis through a central venous catheter (Phase IIa). The goal is to see how safe the drug is and how the body processes it. This could lead to a new treatment option for people on dialysis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy adult aged 18 to 55, or an adult aged 18 or older with end-stage kidney disease on hemodialysis.
- If you have kidney disease, you must use a tunneled central venous catheter for dialysis and have been on dialysis for at least 60 days.
- You should not have certain serious health conditions like recent infections, cancer, or bleeding disorders.
- You must be willing to have blood draws and follow study procedures.
- You cannot be taking long-term antibiotics for a specific type of staph infection (S. aureus) if you are in the kidney disease group.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new study drug called AZD1613 for adults with a certain type of kidney disease (ADPKD). Researchers want to see if it is safe, how the body handles it, and what the right dose might be.
This trial tests an experimental drug (AZD2373) for people with kidney disease caused by APOL1 gene changes. It aims to find the safest and most effective dose to slow kidney damage.
This trial tests a new medication, AZD0780, to see if it helps prevent major cardiovascular events like heart attacks or strokes in people who already have heart or blood vessel disease, or are at high risk for a first event. It might be a good fit if your cholesterol isn't well-controlled despite current treatments.
This is a Phase 1 safety study of a new investigational drug called AZD7760 in healthy Japanese volunteers. The trial will test how the body handles the drug and monitor for any side effects.
This trial tests an experimental drug called AZD4248 to see if it's safe for healthy people and for people with chronic kidney disease and type 2 diabetes. It also checks if a home device can accurately measure kidney function.
This early-phase study tests whether RVX000222 is safe and effective in people with end-stage kidney disease who receive hemodialysis. If you join, you’ll be carefully monitored to see how your body responds and whether it changes kidney-related health measures.
Hear when a new Staphylococcus Aureus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.